NVS Research and Charts

NVS - Novartis AG ADR (Healthcare: Drug Manufacturers - General)

Projected Earnings Date: 2025-07-29 (Delayed quote data 2025-06-30)

Last 121.01	Change ⇑ +0.95 (+0.79%)	Volume 1,280,731
	Open 120.16	High 121.24	Low 120.00

8EMA (Daily) 119.17	40EMA (Daily) 115.55	50EMA (Daily) 114.76	STO (Daily) 75.638	MACD Hist (Daily) 0.281
8EMA (Weekly) 117.124	40EMA (Weekly) 110.60	50EMA (Weekly) 109.63	STO (Weekly) 92.923	MACD Hist (Weekly) 1.816


Company Profile
Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The firm sells its products globally, with the United States representing close to one third of total revenue.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.